Tillman Pearce

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre,…

The Lancet Oncology · 2017 · 258 citations

Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

Inflammatory Bowel Diseases · 2010 · 177 citations